ArticleFrontiers in endocrinology2026
Case Report: Unusual electrolyte changes in primary hyperparathyroidism-a call to suspect underlying Gitelman syndrome.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary hyperparathyroidism (PHPT) is commonly associated with hypercalcemia, hypophosphatemia, and hypercalciuria. Hypokalemia and hypomagnesemia are rare and indicate a complicated etiology. Case presentation: We describe a 74-year-old woman who presented with metabolic encephalopathy and moderate dehydration. Biochemical examinations revealed a parathyroid crisis with severe hypercalcemia (4.18 mmol/L), hypophosphatemia, hypokalemic (2.5 mmol/L) metabolic alkalosis, severe hypomagnesemia (0.23 mmol/L), and a high level of intact parathyroid hormone (243.0 pg/mL). The electrolyte imbalances were resistant to proper hydration and electrolyte replacement. Markedly, urine analysis showed renal potassium and magnesium wasting and severe hypocalciuria (calcium-to-creatinine clearance ratio, 0.0093). The presence of this paradoxical hypocalciuria despite PHPT brought into question the possibility of an underlying renal tubulopathy or accompanying vitamin D deficiency. Vitamin D assay showed deficiency with a level of 14.2 ng/mL. Ultrasound neck and contrast-enhanced computed tomography of the neck showed a right thyroid lesion for which the patient underwent right hemithyroidectomy and parathyroidectomy. Histopathological examination revealed a parathyroid adenoma. Although the patient's hypercalcemia settled postoperatively, hypomagnesemia persisted despite vitamin D supplementation, which indicates the presence of underlying renal tubulopathy, likely Gitelman syndrome. Conclusion: This case emphasizes that persistent hypokalemia, hypomagnesemia, and unexpected hypocalciuria in patients with PHPT should prompt clinicians to suspect concurrent renal tubulopathies such as Gitelman syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.